Double-blind, randomised, placebo-controlled, phase II dose-finding study comparing different doses of RhuDex granules with placebo in the treatment of primary biliary cholangitis
Latest Information Update: 14 Aug 2024
At a glance
- Drugs AV 1142742 (Primary)
- Indications Primary biliary cirrhosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms RhuDex vs placebo in PBC
- Sponsors Dr Falk Pharma
Most Recent Events
- 04 Feb 2024 This trial has been discontinued in Italy, according to European Clinical Trials Database record.
- 15 Jun 2023 This trial has been completed in Germany (Global end date: 3 May 2023).
- 03 May 2023 This trial has been discontinued in Poland, according to European Clinical Trials Database record.